Literature DB >> 33042554

Transmission routes for SARS-CoV-2 infection: review of evidence.

S Falahi1, A Kenarkoohi2.   

Abstract

There is no specific treatment for SARS-CoV-2, and all infection control strategies are based on breaking the transmission chain of virus. The high transmission rate of SARS-CoV-2 has raised many questions about the possible routes of infection transmission. Due to uncertainty of the main transmission routes, the infection control policies faced with more challenges. The possible main route of transmission is thought to be the close contact and respiratory droplets. Therefore, it is necessary to maintain physical distance and using the face mask. Another routes of transmission are through contaminated surfaces as well as airborne, fecal-oral transmission.
© 2020 The Authors.

Entities:  

Keywords:  COVID-19; Close contact; SARS-CoV-2; Transmission routes; droplet

Year:  2020        PMID: 33042554      PMCID: PMC7537649          DOI: 10.1016/j.nmni.2020.100778

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


To the Editor, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still at the forefront of the world's news. There is no vaccine and no drug for the virus, and all infection control strategies are based on breaking the transmission chain of the virus. The ability of the coronavirus family to cross the species barrier was further established when the emerging SARS-CoV-2 was identified (after the identification of the SARS coronavirus in 2003 and Middle East respiratory syndrome (MERS) coronavirus in 2012). SARS-CoV-2 was transmitted from animals to humans, and then between humans at high speed. Now, months after the start of the pandemic, the number of cases is increasing daily. The high transmission rate of SARS-CoV-2 has raised many questions about the possible routes of infection transmission. In the early days of the epidemic, it was thought that transmission was occurring only from symptomatic individuals, but as the story progressed, it became clear that transmission from pre-symptomatic and asymptomatic individuals was possible [1,2]. The uncertainty surrounding the main transmission routes has meant that infection control policies are faced with more challenges. The possible main route of transmission is thought to be close contact and respiratory droplets secreted by the patient during coughing, sneezing, breathing and even normal speech. Therefore, it is necessary to maintain physical distance and to use a face mask. Another route of transmission is through contaminated objects or fomites. Touching the T-zone of the face, after contact with these objects, is also a means of transmission, which emphasizes the need for hand hygiene and hand washing. Subsequent studies have shown that the virus is also present in saliva; given the evidence of virus transmission from asymptomatic individuals [1] and the presence of the virus in saliva, it has been suggested that even secretory droplets during normal speech may be a route for transmission of SARS-CoV-2 [2]. Talking creates droplets that can carry the virus, and this hypothesis also supports the transmission of SARS-CoV-2 by asymptomatic individuals. If we accept this possibility, it is necessary for everyone in the community to wear a mask. There is conflicting evidence for airborne transmission of the virus. A number of studies have reported positive air sampling in closed environments and emphasize the airborne transmission of SARS-CoV-2 [3,4]. Factors such as short sampling time and poor knowledge of sampling operators about the dynamics of droplets and buildings airflow, can lead to a failure to identify SARS-CoV-2 in air samples. Therefore, all necessary measures should be taken to prevent air transmission of SARS-CoV-2, including improving the ventilation system by increasing the ventilation rate per hour, preventing air recirculation, reducing the number of people indoors and preventing direct exposure to a patient's air flow [4]. Airborne transmission emphasizes the importance of using face masks in public, crowded and closed places as the most important preventive measure. Previous experience with coronaviruses has shown that a percentage of infections are related to nosocomial infections [5]. During the sudden onset of an epidemic, there is not enough time for personnel training, so it is crucial to prevent intra-hospital transmission. Therefore, stricter infection prevention and control measures should be implemented in ventilation systems and surface disinfection, and access to personal protective equipment (masks, gloves, shields) should be facilitated. There are several possible routes of transmission: through respiratory droplets, airborne particles, aerosol-generating devices and methods, and contaminated surfaces [6]. However, the exact route of transmission in SARS-CoV-2 nosocomial infection is unknown [7]. In addition to nosocomial transmission in hospitals, we must also pay attention to intra-family transmission. In one study, 16.3% of household transmissions were reported by household contact tracing of index coronavirus disease 2019 (COVID-19) cases; indicating the high transmissibility of SARS-CoV-2 [6]. Household contact tracing of index COVID-19 cases can be applied as an important part of COVID-19 control programmes. Although contact tracing is necessary and effective for controlling COVID-19, because of the presence of asymptomatic and pre-symptomatic transmission, it is not sufficient to interrupt transmission, so physical/social distancing should be implemented. SARS-CoV-2 RNA has been detected from the faeces of infected individuals and from hospital toilet bowls. Although viral RNA detection is not equivalent to a viable virus, it is a trace of the virus, so faecal–oral transmission may be possible [5,8]. Angiotensin-converting enzyme 2 is present in the gastrointestinal tract, so SARS-CoV-2 may enter the gastrointestinal tract and replicate. As a result of the digestive symptoms in some patients and prolonged viral shedding in faeces, the virus appears to actively proliferate in the gastrointestinal tract [9]. Therefore, there is a possibility of infection transmission in toilets through the creation of aerosols when flushing toilets and through surfaces contact. The potential for faecal–oral transmission also emphasizes the importance of hand hygiene and washing. There is conflicting evidence about vertical transmission. Some studies have followed infants born to infected pregnant women and taken pharyngeal samples for RT-PCR testing, but the results were negative and showed that the infants were not infected with SARS-CoV-2 [10]. Other studies did not rule out vertical transmission. In one study, PCR testing of neonatal pharyngeal samples was negative, but IgM and IgG antibodies against COVID-19 were positive on the day of birth. The mother's vaginal discharge was also negative [11]. In another study, 33 infants born to pregnant women with COVID-19 were screened, and three infants tested positive by PCR for SARS-CoV-2 on the second day of life [12]. SARS-CoV-2 nucleic acid has been detected in the placenta [13]. On the other side of the coin, there are studies that show the impossibility of vertical transmission: in one study, all products of pregnancy from two pregnant women were negative or SARS-CoV-2 [10]. In general, because of the presence of angiotensin-converting enzyme 2 on placental villi and the uterus [14], vertical transmission can occur, although the risk seems very low. In a number of studies, the SARS-CoV-2 genome was identified in blood samples from a number of patients with COVID-19 [15,16], which raised the question: Is SARS-CoV-2 transmitted through transfusion? In one study, all blood samples taken from asymptomatic people with COVID-19 were negative for SARS-CoV-2 by PCR, and RNAemia was detected in severe and symptomatic cases. People with symptoms of infectious disease are not accepted by blood transfusion organizations, so there is no chance of transmission through transfusion, or the risk is very low. In addition, the viral load is low in serum and plasma. In previous viruses of this family (SARS and MERS coronaviruses), no cases of transfusion transmission have been reported [16]; the similarity of SARS-CoV-2 with SARS also supports the hypothesis of non-transmission through blood. SARS-CoV-2 is present in saliva and faeces, and in theory it would be possible to transmit the virus through oral–anal intercourse [17], but this sexual habit is not common, so it is unlikely that this route will be a significant means of transmission. In summary, considering the high transmission capacity of SARS-CoV-2, prolonged viral shedding, and the lack of a vaccine and systematic medication at this time, the most important action to limit infection is to cut off the transmission chain.

Conflict of interest

Authors declared no conflict of interest.
  16 in total

1.  SARS-CoV-2 infection of the placenta.

Authors:  Hillary Hosier; Shelli F Farhadian; Raffaella A Morotti; Uma Deshmukh; Alice Lu-Culligan; Katherine H Campbell; Yuki Yasumoto; Chantal Bf Vogels; Arnau Casanovas-Massana; Pavithra Vijayakumar; Bertie Geng; Camila D Odio; John Fournier; Anderson F Brito; Joseph R Fauver; Feimei Liu; Tara Alpert; Reshef Tal; Klara Szigeti-Buck; Sudhir Perincheri; Christopher Larsen; Aileen M Gariepy; Gabriela Aguilar; Kristen L Fardelmann; Malini Harigopal; Hugh S Taylor; Christian M Pettker; Anne L Wyllie; Charles Dela Cruz; Aaron M Ring; Nathan D Grubaugh; Albert I Ko; Tamas L Horvath; Akiko Iwasaki; Uma M Reddy; Heather S Lipkind
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

2.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

3.  The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.

Authors:  Yifei Chen; Liangjun Chen; Qiaoling Deng; Guqin Zhang; Kaisong Wu; Lan Ni; Yibin Yang; Bing Liu; Wei Wang; Chaojie Wei; Jiong Yang; Guangming Ye; Zhenshun Cheng
Journal:  J Med Virol       Date:  2020-04-25       Impact factor: 2.327

4.  Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?

Authors:  Angela Patrì; Lucia Gallo; Maria Guarino; Gabriella Fabbrocini
Journal:  J Am Acad Dermatol       Date:  2020-04-09       Impact factor: 11.527

5.  Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.

Authors:  Wycliffe E Wei; Zongbin Li; Calvin J Chiew; Sarah E Yong; Matthias P Toh; Vernon J Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

6.  Nosocomial Transmission of Coronavirus Disease 2019: A Retrospective Study of 66 Hospital-acquired Cases in a London Teaching Hospital.

Authors:  Hannah M Rickman; Tommy Rampling; Karen Shaw; Gema Martinez-Garcia; Leila Hail; Pietro Coen; Maryam Shahmanesh; Gee Yen Shin; Eleni Nastouli; Catherine F Houlihan
Journal:  Clin Infect Dis       Date:  2021-02-16       Impact factor: 9.079

7.  Airborne transmission of SARS-CoV-2: The world should face the reality.

Authors:  Lidia Morawska; Junji Cao
Journal:  Environ Int       Date:  2020-04-10       Impact factor: 9.621

8.  Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19).

Authors:  Shihua Luo; Xiaochun Zhang; Haibo Xu
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-20       Impact factor: 11.382

9.  SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.

Authors:  Victor M Corman; Holger F Rabenau; Ortwin Adams; Doris Oberle; Markus B Funk; Brigitte Keller-Stanislawski; Jörg Timm; Christian Drosten; Sandra Ciesek
Journal:  Transfusion       Date:  2020-05-27       Impact factor: 3.337

10.  Nosocomial SARS-CoV-2 infection among nurses in Wuhan at a single centre.

Authors:  Huimin Sun; Mengxin Lu; Song Chen; Zhenshun Cheng; Yong Xiong; Xinghuan Wang
Journal:  J Infect       Date:  2020-04-10       Impact factor: 6.072

View more
  14 in total

Review 1.  Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal:  ACS Infect Dis       Date:  2022-08-08       Impact factor: 5.578

Review 2.  Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination.

Authors:  Esmail Rayatdoost; Mohammad Rahmanian; Mohammad Sadegh Sanie; Jila Rahmanian; Sara Matin; Navid Kalani; Azra Kenarkoohi; Shahab Falahi; Amir Abdoli
Journal:  Yale J Biol Med       Date:  2022-06-30

Review 3.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

Review 4.  Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic.

Authors:  Kazunori Yamaji; Yoshiaki Mitsutake; Masaharu Nakano; Takuya Nakamura; Yoshihiro Fukumoto
Journal:  J Cardiol       Date:  2021-08-19       Impact factor: 3.159

5.  The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate.

Authors:  Tuksin Jearanaiwitayakul; Jitra Limthongkul; Chernkhwan Kaofai; Suttikarn Apichirapokey; Runglawan Chawengkirttikul; Sompong Sapsutthipas; Panya Sunintaboon; Sukathida Ubol
Journal:  Biomedicines       Date:  2022-05-16

6.  Multiple relationships between aerosol and COVID-19: A framework for global studies.

Authors:  Yaxin Cao; Longyi Shao; Tim Jones; Marcos L S Oliveira; Shuoyi Ge; Xiaolei Feng; Luis F O Silva; Kelly BéruBé
Journal:  Gondwana Res       Date:  2021-02-09       Impact factor: 6.051

Review 7.  Are beliefs and attitudes about COVID-19 associated with self-perceived changes in food consumption? Results from a nationwide survey during lockdown.

Authors:  Raquel Martins; Carolina Capitão; Mónica Fialho; Rodrigo Feteira-Santos; Ana Virgolino; Ricardo R Santos; Violeta Alarcão; Marlene Silva; Miguel Arriaga; Pedro Graça; Maria João Gregório; Osvaldo Santos
Journal:  Appetite       Date:  2021-09-07       Impact factor: 5.016

Review 8.  Host factors and vaccine efficacy: Implications for COVID-19 vaccines.

Authors:  Shahab Falahi; Azra Kenarkoohi
Journal:  J Med Virol       Date:  2021-12-07       Impact factor: 20.693

9.  Widespread contamination of SARS-CoV-2 on highly touched surfaces in Brazil during the second wave of the COVID-19 pandemic.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Wendell Palôma Maria Dos Santos Reis; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Renata Pessôa Germano Mendes; Allyson Andrade Mendonça; Bárbara Nazly Rodrigues Santos; Jurandy Júnior Ferraz de Magalhães; Alain Kohl; Lindomar Pena
Journal:  Environ Microbiol       Date:  2021-12       Impact factor: 5.476

10.  Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization.

Authors:  Veronica Di Sarno; Gianluigi Lauro; Simona Musella; Tania Ciaglia; Vincenzo Vestuto; Marina Sala; Maria Carmina Scala; Gerardina Smaldone; Francesca Di Matteo; Sara Novi; Mario Felice Tecce; Ornella Moltedo; Giuseppe Bifulco; Pietro Campiglia; Isabel M Gomez-Monterrey; Robert Snoeck; Graciela Andrei; Carmine Ostacolo; Alessia Bertamino
Journal:  Eur J Med Chem       Date:  2021-09-22       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.